National Health Investors (NYSE: NHI) reported Q3 normalized FFO of $0.80, $0.01 better than the analyst estimate of $0.79. Revenue for the quarter came in at $25.51 million versus the consensus estimate of $22.51 million.

National Health Investors sees FY2012 EPS of $3.15-3.18, versus the consensus of $3.12.

For earnings history and earnings-related data on National Health Investors (NHI) click here.

Earnings Guidance Hot Guidance